Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$36.94
Total Value
$73.88K
Shares Held After
128,443
% of Holdings
1.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bhatia Sangeeta N. — Director
Shares
266
Price
$500.00
Total Value
$133.00K
Shares Held After
4,299
% of Holdings
5.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
988
Price
$499.00
Total Value
$493.01K
Shares Held After
16,838
% of Holdings
5.5%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
1,530
Price
$7.79
Total Value
$11.92K
Shares Held After
47,872
% of Holdings
3.1%
PULSE BIOSCIENCES, INC. (PLSE)
Danahy Kevin Patrick — Chief Commercial Officer
Shares
20,000
Price
$23.53
Total Value
$470.60K
Shares Held After
43,298
% of Holdings
31.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
23,305
% of Holdings
7.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
59,802
% of Holdings
3.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
1,959
Price
$310.08
Total Value
$607.45K
Shares Held After
31,769
% of Holdings
5.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
6,958
Price
$310.08
Total Value
$2.16M
Shares Held After
85,662
% of Holdings
7.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
2,242
Price
$310.08
Total Value
$695.20K
Shares Held After
24,848
% of Holdings
8.3%
QUEST DIAGNOSTICS INC (DGX)
Doherty Catherine T. — EVP, Regional Businesses
Shares
351
Price
$209.10
Total Value
$73.39K
Shares Held After
68,068
% of Holdings
0.5%
QUEST DIAGNOSTICS INC (DGX)
Doherty Catherine T. — EVP, Regional Businesses
Shares
1,619
Price
$208.21
Total Value
$337.09K
Shares Held After
68,419
% of Holdings
2.3%
QUEST DIAGNOSTICS INC (DGX)
Doherty Catherine T. — EVP, Regional Businesses
Shares
3,500
Price
$207.08
Total Value
$724.79K
Shares Held After
70,038
% of Holdings
4.8%
QUEST DIAGNOSTICS INC (DGX)
Doherty Catherine T. — EVP, Regional Businesses
Shares
10,122
Price
$206.37
Total Value
$2.09M
Shares Held After
73,538
% of Holdings
12.1%
QUEST DIAGNOSTICS INC (DGX)
Doherty Catherine T. — EVP, Regional Businesses
Shares
10,573
Price
$205.21
Total Value
$2.17M
Shares Held After
83,660
% of Holdings
11.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$102.09
Total Value
$204.18K
Shares Held After
0
% of Holdings
100.0%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$76.80
Total Value
$38.40K
Shares Held After
69,329
% of Holdings
0.7%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
10,000
Price
$5.81
Total Value
$58.14K
Shares Held After
204,657
% of Holdings
4.7%
Twist Bioscience Corp (TWST)
Finn Patrick John — President and COO
Shares
1,750
Price
$50.04
Total Value
$87.57K
Shares Held After
306,250
% of Holdings
0.6%
Hyperfine, Inc. (HYPR)
TEISSEYRE THOMAS — Chief Operating Officer
Shares
821
Price
$1.11
Total Value
$912.54
Shares Held After
378,836
% of Holdings
0.2%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
16,100
Price
$8.96
Total Value
$144.27K
Shares Held After
258,792
% of Holdings
6.2%
EKSO BIONICS HOLDINGS, INC. (EKSO)
ASHER DANIEL — 10% Owner
Shares
11,092
Price
$9.14
Total Value
$101.41K
Shares Held After
242,692
% of Holdings
4.6%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
225,000
Price
$26.50
Total Value
$5.96M
Shares Held After
15,127,329
% of Holdings
1.5%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
150,784
Price
$26.49
Total Value
$3.99M
Shares Held After
15,352,329
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.58
Total Value
$175.10K
Shares Held After
44,089
% of Holdings
12.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
4,166
Price
$27.33
Total Value
$113.86K
Shares Held After
50,437
% of Holdings
7.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
3,541
Price
$27.33
Total Value
$96.78K
Shares Held After
50,437
% of Holdings
6.6%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
6,207
Price
$82.07
Total Value
$509.40K
Shares Held After
32,105
% of Holdings
16.2%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
9,435
Price
$81.56
Total Value
$769.51K
Shares Held After
38,312
% of Holdings
19.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
4,160
Price
$26.36
Total Value
$109.66K
Shares Held After
19,860
% of Holdings
20.9%
QuidelOrtho Corporation (QDEL)
Strobeck Matthew — Director
Shares
10,000
Price
$23.96
Total Value
$239.59K
Shares Held After
27,775
% of Holdings
36.0%
IRADIMED CORP (IRMD)
ALLEN MONTY K — Director
Shares
1,000
Price
$100.26
Total Value
$100.26K
Shares Held After
21,000
% of Holdings
4.5%
QuidelOrtho Corporation (QDEL)
Busky Joseph M. — Chief Financial Officer
Shares
3,370
Price
$23.66
Total Value
$79.74K
Shares Held After
10,290
% of Holdings
32.8%
QuidelOrtho Corporation (QDEL)
Blaser Brian J. — President and CEO
Shares
10,540
Price
$23.59
Total Value
$248.66K
Shares Held After
40,073
% of Holdings
26.3%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
35,000
Price
$0.03
Total Value
$1.14K
Shares Held After
30,210,988
% of Holdings
0.1%
TALPHERA, INC. (TLPH)
ASADORIAN RAFFI — Chief Financial Officer
Shares
45,000
Price
$0.81
Total Value
$36.55K
Shares Held After
91,256
% of Holdings
49.3%
TALPHERA, INC. (TLPH)
Aslam Shakil — Chief Medical Officer
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
83,178
% of Holdings
42.1%
TALPHERA, INC. (TLPH)
Angotti Vincent J. — Director
Shares
105,364
Price
$0.81
Total Value
$85.59K
Shares Held After
586,954
% of Holdings
18.0%
TALPHERA, INC. (TLPH)
Dasu Badri N — Chief Engineering Officer
Shares
35,000
Price
$0.81
Total Value
$28.43K
Shares Held After
76,230
% of Holdings
45.9%
Cannabis Sativa, Inc. (CBDS)
TOBIAS DAVID — Director
Shares
300,000
Price
$0.02
Total Value
$5.58K
Shares Held After
25,393
% of Holdings
92.2%
Neuronetics, Inc. (STIM)
MACAN WILLIAM ANDREW — EVP, CLO and CS
Shares
14,120
Price
$1.65
Total Value
$23.30K
Shares Held After
673,561
% of Holdings
2.1%
Neuronetics, Inc. (STIM)
Sullivan Keith J — Director
Shares
33,847
Price
$1.65
Total Value
$55.85K
Shares Held After
1,533,165
% of Holdings
2.2%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
10,348
Price
$9.04
Total Value
$93.55K
Shares Held After
332,412
% of Holdings
3.0%
OCULAR THERAPEUTIX, INC (OCUL)
Dugel Pravin — Director
Shares
124,882
Price
$9.04
Total Value
$1.13M
Shares Held After
3,033,078
% of Holdings
4.0%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
11,446
Price
$9.04
Total Value
$103.47K
Shares Held After
366,356
% of Holdings
3.0%
PULSE BIOSCIENCES, INC. (PLSE)
Danahy Kevin Patrick — Chief Commercial Officer
Shares
20,000
Price
$23.37
Total Value
$467.40K
Shares Held After
43,298
% of Holdings
31.6%
Showing 851–900 of 1586 transactions (page 18 of 32)